USE OF SUBCUTANEOUS IMMUNOGLOBULIN IN PATIENTS ON CONCOMITANT ANTICOAGULANT AND ANTIPLATELET THERAPY

被引：0
|
作者：
Stein, M. R. [1 ]
Farnan, K. [1 ]
Eufrasio, D. [1 ]
Duff, C. [2 ]
Hunter, J. [3 ]
Ochoa, D. [4 ]
Levasseur, M. -C. [5 ]
Aro, L. [6 ]
Zampelli, A. [7 ]
机构：
[1] Allergy Associates Palm Beaches, N Palm Beach, FL USA
[2] Univ S Florida, Tampa, FL USA
[3] Arizona Allergy Associates, Phoenix, AZ USA
[4] Allergy Immunol Res Ctr N Texas, Dallas, TX USA
[5] Hop St Justine, Univ Hlth Ctr, Montreal, PQ H3T 1C5, Canada
[6] Toronto Allergy Grp, Toronto, ON, Canada
[7] CSL Behring LLC, King Of Prussia, PA USA
来源：
JOURNAL OF CLINICAL IMMUNOLOGY | 2012年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：347 / 348
页数：2
相关论文
共 50 条
  • [1] Use of Subcutaneous IgG in Patients on Concomitant Anticoagulant and Antiplatelet Therapy
    Stein, Mark R.
    Farnan, Kelly
    Eufrasio, Danielle
    Duff, Carla
    Hunter, Jerry
    Ochoa, Diana
    Levasseur, Marie-Claude
    Aro, Loris
    Zampelli, Annette
    JOURNAL OF CLINICAL IMMUNOLOGY, 2012, 32 (02) : 370 - 370
  • [2] Tolerability of Subcutaneous Immunoglobulin (SCIG) in Patients Receiving Antiplatelet (AP) and Anticoagulant (AC) Therapy
    Kuryan, J.
    Galowitz, S.
    Kaplan, B.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) : AB247 - AB247
  • [3] Retrospective evaluation of the use of proton pump inhibitors in patients on concomitant anticoagulant and antiplatelet therapy
    Patil, Tanvi
    Murphy, Kimberly
    Woodard, Laura
    Lebrecht, Morgan
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2019, 47 (04) : 616 - 616
  • [4] Clinical outcome in patients with venous thromboembolism receiving concomitant anticoagulant and antiplatelet therapy
    Tzoran, Inna
    Brenner, Benjamin
    Sakharov, Gleb
    Trujillo-Santos, Javier
    Lorenzo, Alicia
    Madridano, Olga
    Bosco Lopez-Saez, Juan
    Monreal, Manuel
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2014, 25 (09) : 821 - 825
  • [5] Major Bleeding Complications Among Patients Treated with Ibrutinib and Concomitant Antiplatelet, Anticoagulant, or Supplemental Therapy
    Pavlik, Aaron
    Barr, Hallie
    Dotson, Emily
    Byrd, John C.
    Blum, Kristie A.
    Awan, Farrukh T.
    Woyach, Jennifer A.
    Maddocks, Kami J.
    Christian, Beth A.
    Jones, Jeffrey
    BLOOD, 2016, 128 (22)
  • [6] Shift in Patterns in Previous Immunoglobulin Therapy Use in Patients Prescribed 20% Subcutaneous Immunoglobulin
    Botteman, Marc
    Zbrozek, Art
    Bullinger, Ann
    Baptist, Alan P.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 131 (02) : AB156 - AB156
  • [7] Antiplatelet and anticoagulant therapy in patients with advanced heart failure
    Lip, GYH
    Chung, I
    THROMBOSIS RESEARCH, 2005, 116 (04) : 275 - 277
  • [8] Combined antiplatelet and anticoagulant therapy for patients with mitral stenosis
    Claire Braybrook
    Nature Clinical Practice Cardiovascular Medicine, 2006, 3 (3): : 122 - 123
  • [9] Antiplatelet and anticoagulant therapy in patients with giant cell arteritis
    Lee, Michael S.
    Smith, Scott D.
    Galor, Anat
    Hoffman, Gary S.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (10): : 3306 - 3309
  • [10] Combination Anticoagulant and Antiplatelet Therapy in Atrial Fibrillation Patients
    Lip, Gregory Y. H.
    Lane, Deirdre A.
    REVISTA ESPANOLA DE CARDIOLOGIA, 2009, 62 (09): : 972 - 975
12345